Á¦51Â÷ ´ëÇѼҾƳ»ºÐºñÇÐȸ Ãß°èÇмú´ëȸ : 2022-10-21±³À°ÀÏÀÚ : 2022-10-21
±³À°Àå¼Ò : ±×·£µå¿öÄ¿ÈúÈ£ÅÚ ¿öĿȦ1
±³À°ÁÖÁ¦ :
Á¦51Â÷ ´ëÇѼҾƳ»ºÐºñÇÐȸ Ãß°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѼҾƳ»ºÐºñÇÐȸ
´ã´çÀÚ : Á¶ÁÖ¿¬
¿¬¶ôó : 02-3471-4268
À̸ÞÀÏ :
kspendo@gmail.com ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 4 ½Ã°£ 5ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í »çÀüµî·Ï: ȸ¿ø 40000¿ø, ºñȸ¿ø 60000¿ø, Àü°øÀÇ 20000¿ø ÇöÀåµî·Ï: ȸ¿ø 50000¿ø, ºñȸ¿ø 70000¿ø, Àü°øÀÇ 20000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-21 13:35~14:15 Recent progress in genetic research on type 2 DM °û¼öÇå(¼¿ïÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 10-21 14:15~14:40 »çÃá±â ¿¬±¸ °æÇè Á¤È°¸²(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 10-21 15:00~15:30 New paradigm for obesity medications Àå°æ¹Ì(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 10-21 15:30~16:00 Next-generation insulin analogues äÇö¿í(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-21 16:00~16:30 Long-acting GnRHa: New Treatment for Central Precocious Puberty ¾È¹®¹è(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-21 16:30~17:00 Novel therapies for FGFR3-related skeletal dysplasia °íÁ¤¹Î(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-21 17:00~17:30 Potential treatment for pediatric osteoporosis °¹ÎÀç(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-21 17:30~18:00 New therapeutic targets for CAH ±èÀÚÇý(¿ï»êÀÇ´ë)